EYE ALLERGY RELIEF- pheniramine maleate and naphazoline hydrochloride solution/ drops 
Target Corporation

----------

Drug Facts

Active ingredients

Naphazoline HCl (0.02675%)

Pheniramine maleate (0.315%)

Purpose

Redness reliever

Antihistamine

Uses

Warnings

For external use only

Do not use

  • if you are sensitive to any ingredient in this product
  • if solution changes color or becomes cloudy

Ask a doctor before use if you have

  • heart disease
  • high blood pressure
  • trouble urinating due to an enlarged prostate gland
  • narrow angle glaucoma

When using this product

  • overuse may cause more eye redness
  • pupils may become enlarged temporarily
  • do not touch tip of container to any surface to avoid contamination
  • you may feel a brief tingling after putting drops in eye
  • replace cap after use
  • remove contact lenses before using

Stop use and ask a doctor if you experience

  • eye pain
  • changes in vision
  • redness or irritation of the eye that worsens or lasts more than 72 hours

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.

Directions

Other information

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, hypromellose, purified water, sodium borate, sodium chloride. Hydrochloric acid may be used to adjust pH.

Questions or comments?

[phone icon] call: 1-800-910-6874

Package/Label Principal Display Panel

carton

NDC 11673-430-15

Compare to
Opcon-A® active ingredient*

Eye Allergy
Relief Drops

pheniramine maleate 0.315%
and naphazoline
hydrochloride 0.02675%
ophthalmic solution

ANTIHISTAMINE AND
REDNESS RELIEVER

Relieves itching and
redness caused by grass,
ragweed, pollen, animal
hair and dander
[arrow icon] up&up™

STERILE 0.5 FL OZ (15 mL) 9383104

EYE ALLERGY RELIEF 
pheniramine maleate and naphazoline hydrochloride solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-430
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE0.2675 mg  in 1 mL
PHENIRAMINE MALEATE (UNII: NYW905655B) (PHENIRAMINE - UNII:134FM9ZZ6M) PHENIRAMINE MALEATE3.15 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11673-430-151 in 1 CARTON08/31/2010
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02006508/31/2010
Labeler - Target Corporation (006961700)
Registrant - Bausch & Lomb Incorporated (196603781)
Establishment
NameAddressID/FEIBusiness Operations
Bausch & Lomb Incorporated114406598manufacture(11673-430)
Establishment
NameAddressID/FEIBusiness Operations
Bausch & Lomb Incorporated079587625manufacture(11673-430)

Revised: 3/2025
Document Id: 316ecb95-254a-e9ab-e063-6294a90a7509
Set id: 806ad1b6-0de7-4e9a-be86-475c0ef2c340
Version: 10
Effective Time: 20250328
 
Target Corporation